C ryptorchidism (CO) and hypospadias (HS) are common congenital abnormalities that affect B1% of full-term male newborns. 1-3 CO and HS usually occur as multifactorial traits subject to a number of genetic and environmental factors with relatively minor effects, although in rare cases these conditions can occur as monogenic disorders because of mutations in genes such as AR and SRD5A2. 2,3 During the last few decades, the prevalence of undermasculinized male genitalia, including HS and CO, has increased in several countries. 4 Similarly, compromised male reproductive function has recently been documented in various wildlife species. 5 The rapid increase in the prevalence of undermasculinized genitalia indicates that intrauterine exposure to environmental chemicals with endocrine-disrupting properties (environmental endocrine disruptors (EEDs)) has a role in the development of such abnormalities, because large quantities of EEDs have been released into the environment in recent decades. 5 Consistent with this notion, studies on laboratory animals have shown that intrauterine and lactational exposure to EEDs, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin, affects the reproductive system of male offsprings. 1,5 The effect of EEDs on male reproductive organs appears to depend on the susceptibility of the individual, in addition to the dosage and types of EEDs and the developmental stages of exposure. Till date, several association studies have been performed for patients with CO and HS, in order to identify genetic variants that predispose individuals to these conditions. 2,3 Consequently, polymorphisms in several genes, such as AR, ESR1, ESR2 and SRD5A2, have been identified as the disease-associated variants. 2,3 However, polymorphisms in genes involved in EED metabolism have been poorly investigated in patients with CO and HS.In this issue of the Journal, Qin et al. 6 report an association between single-nucleotide polymorphisms (SNPs) in genes involved in EED metabolism and the risk of CO and HS. They examined 384 SNPs of 15 genes in 334 Japanese male subjects (95 patients with CO, 98 patients with HS and 141 unaffected controls) and 187 Italian male subjects (58 patients with CO and 129 controls), and identified SNPs in 5 genes that were over-represented in the patient group(s) in comparison with the control group. Notably, a significant association was found between SNPs in the aryl hydrocarbon receptor nuclear translocator 2 gene (ARNT2) and the risk of CO and HS in both the Japanese and Italian groups. Furthermore, a SNP in the aryl hydrocarbon receptor gene (AHR) was found to be associated with CO in the Italian group. In this regard, it is noteworthy that both ARNT2 and AHR have been implicated in the dioxin signaling pathway. 1,7 In the cytoplasm, dioxins bind to AHR and the ligand-bound AHR dimerizes with ARNT. The ligand-activated AHR-ARNT heterodimer then transactivates several target genes and modulates estrogen receptor signaling. 1 ARNT2 has homology with ARNT and is predicted to interact with AHR. 7 ...